Recurrence in the breast following conservative surgery and radiation therapy for early-stage breast cancer.
Frank A. Vicini(Radiation Oncology Institute), William Silen(Beth Israel Deaconess Hospital), Anthony Abner(Dana-Farber Brigham Cancer Center), Rebecca Gelman(Dana-Farber Cancer Institute), John Boyages(Australian Cancer Research Foundation), S J Schnitt, R T Osteen(Harvard University Press), Abram Recht(Beth Israel Deaconess Medical Center), James L. Connolly(Beth Israel Deaconess Medical Center), Blake Cady(Harvard University)
PubMed
January 1, 1992
Cited by 65
Related Papers
Molecular Definition of Breast Tumor Heterogeneity
|Cancer Cell|2007|1.4k
Revision of the American Joint Committee on Cancer Staging System for Breast Cancer
|Journal of Clinical Oncology|2002|1.2k
Prognostic Factors in Breast Cancer
|Archives of Pathology & Laboratory Medicine|2000|1.1k
Breast Cancer—Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual
|CA A Cancer Journal for Clinicians|2017|988
Efficacy of Neoadjuvant Cisplatin in Triple-Negative Breast Cancer
|Journal of Clinical Oncology|2010|983